CBLN1 and cancer: Lipidomic analysis of EVs from different human cell lines and colorectal cancer patients revealed distinct lipid signatures linked to cancer stage, i.e., primary cancer EVs had increased levels of PC 34:1 and PE 36:2, while metastatic conditions showed a decrease in these lipids but an increase in Cer(d18:1/24:1)[102].